Geode Capital Management, LLC Black Diamond Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 944,877 shares of BDTX stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

944,877

Previous 842,432 12.16%

Holding current value

$2.07 Million

Previous $3.93 Million 4.71%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.2 - $6.58 $430,269 - $674,088	102,445 Added 12.16%	944,877 $4.11 Million
Q2 2024 Aug 09, 2024	BUY	$4.65 - $7.39 $2.14 Million - $3.4 Million	459,819 Added 120.18%	842,432 $3.93 Million
Q1 2024 May 13, 2024	BUY	$2.67 - $5.74 $85,885 - $184,638	32,167 Added 9.18%	382,613 $1.94 Million
Q4 2023 Feb 13, 2024	BUY	$1.77 - $3.03 $46,294 - $79,249	26,155 Added 8.07%	350,446 $984,000
Q3 2023 Nov 13, 2023	BUY	$2.87 - $4.99 $152,351 - $264,889	53,084 Added 19.57%	324,291 $930,000
Q2 2023 Aug 11, 2023	BUY	$1.43 - $6.18 $1,113 - $4,814	779 Added 0.29%	271,207 $1.37 Million
Q1 2023 May 15, 2023	BUY	$1.35 - $3.14 $6,936 - $16,133	5,138 Added 1.94%	270,428 $511,000
Q4 2022 Feb 13, 2023	BUY	$1.27 - $2.51 $943 - $1,864	743 Added 0.28%	265,290 $477,000
Q3 2022 Nov 14, 2022	BUY	$1.68 - $4.01 $29,969 - $71,534	17,839 Added 7.23%	264,547 $447,000
Q2 2022 Aug 12, 2022	SELL	$1.5 - $3.63 $277,974 - $672,697	-185,316 Reduced 42.89%	246,708 $606,000
Q1 2022 May 13, 2022	BUY	$2.66 - $5.61 $95,379 - $201,157	35,857 Added 9.05%	432,024 $1.2 Million
Q4 2021 Feb 11, 2022	BUY	$5.18 - $8.48 $239,248 - $391,665	46,187 Added 13.2%	396,167 $2.11 Million
Q3 2021 Nov 12, 2021	SELL	$8.46 - $12.42 $81,402 - $119,505	-9,622 Reduced 2.68%	349,980 $2.96 Million
Q2 2021 Aug 13, 2021	BUY	$12.19 - $28.17 $757,791 - $1.75 Million	62,165 Added 20.9%	359,602 $4.38 Million
Q1 2021 May 12, 2021	BUY	$22.23 - $34.75 $611,591 - $956,042	27,512 Added 10.19%	297,437 $7.22 Million
Q4 2020 Feb 12, 2021	BUY	$29.47 - $35.0 $654,204 - $776,965	22,199 Added 8.96%	269,925 $8.65 Million
Q3 2020 Nov 13, 2020	BUY	$26.17 - $43.07 $1.73 Million - $2.84 Million	65,962 Added 36.29%	247,726 $7.49 Million
Q2 2020 Aug 13, 2020	BUY	$22.3 - $44.8 $2.04 Million - $4.09 Million	91,367 Added 101.07%	181,764 $7.66 Million
Q1 2020 May 14, 2020	BUY	$18.18 - $39.48 $1.64 Million - $3.57 Million	90,397 New	90,397 $2.26 Million

Others Institutions Holding BDTX

# of Institutions

117

Shares Held

48.8M

Call Options Held

1.84M

Put Options Held

1.93M

View Full List

About Black Diamond Therapeutics, Inc.

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $79.6M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

More about BDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Black Diamond Therapeutics, Inc. Transaction History